Danazol's use for menstrual suppression in transgender individuals: A retrospective multi-site cohort study.
Ava ScatoniZaine RobertsElizabeth R BoskeySteven StaffaRosemary Claire RodenEmile RedwoodFrances W GrimstadPublished in: Women's health (London, England) (2024)
Danazol may be a reasonable option for menstrual suppression in transgender and nonbinary patients. Our findings show its potential to not only induce amenorrhea but cause desired androgenic symptoms and improve gender dysphoria, pelvic pain, dysmenorrhea, endometriosis, and heavy bleeding. While the androgenic effects of danazol are less desirable in cisgender populations, it is an attractive option for menstrual suppression in transgender and nonbinary patients.